Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine

Clemens Warnke1, Heinz Wiendl2, Hans-Peter Hartung1, Olaf Stüve3, Bernd C Kieseier11Department of Neurology, Heinrich-Heine University Düsseldorf, Germany; 2Department of Neurology – Inflammatory Disorders of the Nervous System and Neurooncology, University of...

Full description

Bibliographic Details
Main Authors: Clemens Warnke, Heinz Wiendl, Hans-Peter Hartung, et al
Format: Article
Language:English
Published: Dove Medical Press 2010-06-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/identification-of-targets-and-new-developments-in-the-treatment-of-mul-a4614

Internet

http://www.dovepress.com/identification-of-targets-and-new-developments-in-the-treatment-of-mul-a4614

Similar Items